Express Pharma

Pfizer COVID vaccine price hike seen giving revenue boost for years

The drugmaker, which developed and sells the vaccine with Germany's BioNTech said last week that it is targetting a range of $110 to $130 a dose for the vaccine once the US moves to a commercial market next year

0 242